Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GB hMG

Next Previous
Drug Profile

GB hMG

Alternative Names: GB-hMG; Menopausal gonadotropin program - Granata Bio; Menotropins - Granata Bio

Latest Information Update: 10 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Granata Bio
  • Class Gonadotropins; Infertility therapies; Menotropins
  • Mechanism of Action Gonadotropin stimulants; Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Infertility

Most Recent Events

  • 23 May 2025 GB hMG is available for licensing as of 23 May 2025. https://www.granata.bio/join-us
  • 13 May 2025 Early research in Infertility in USA (SC) prior to May 2025 (Granata Bio pipeline, May 2025)
  • 25 Oct 2024 Phase-I clinical trials in Infertility in Australia (SC) (ACTRN12624001371583)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top